Linked Life Data

9314945

Source:http://linkedlifedata.com/resource/pubmed/id/9314945

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9314945rdf:typepubmed:Citationlld:pubmed
pubmed-article:9314945lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:9314945lifeskim:mentionsumls-concept:C1516213lld:lifeskim
pubmed-article:9314945lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:9314945lifeskim:mentionsumls-concept:C0005767lld:lifeskim
pubmed-article:9314945lifeskim:mentionsumls-concept:C0334227lld:lifeskim
pubmed-article:9314945lifeskim:mentionsumls-concept:C0010806lld:lifeskim
pubmed-article:9314945lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:9314945lifeskim:mentionsumls-concept:C0599161lld:lifeskim
pubmed-article:9314945lifeskim:mentionsumls-concept:C1519595lld:lifeskim
pubmed-article:9314945pubmed:issue3lld:pubmed
pubmed-article:9314945pubmed:dateCreated1997-10-23lld:pubmed
pubmed-article:9314945pubmed:abstractTextConflicting results have been reported on the use of cytokeratin-19 (CK-19) in the detection of tumor cells in the peripheral blood of patients with solid tumors. We investigated the expression of CK-19 in lung cancer cell lines and in human lung tumor samples using a nested reverse transcriptase (RT)-PCR to determine the sensitivity and specificity of this method. In addition, blood samples of lung cancer patients and healthy controls were analyzed for the presence of CK-19 transcripts. Amplification products were visualized by ethidium bromide staining and radioactive hybridization with a CK-19-specific probe. Application of a previously described nested RT-PCR for the detection of CK-19 resulted in amplification of the processed pseudogene. Therefore, a more stringent RT-PCR was developed by increasing the annealing temperature. RT-PCR amplification products for CK-19 were detected in 38 of 41 lung cancer cell lines. The three negative cell lines were all variant small-cell lung cancer cell lines. Concordant results were observed between CK-19 detection by immunohistochemistry and by RT-PCR. In serial RNA dilution experiments, CK-19 transcripts could be detected in 18 to 80 pg of total cellular RNA in three cell lines and in 60 ng total RNA in one cell line. The nested RT-PCR had the sensitivity of detecting 50 tumor cells in 10(6) peripheral blood mononuclear cells (PBMNC), and CK-19 transcripts were randomly detected in normal PBMNC. This study shows the necessity in processing parallel samples without reverse transcriptase enzyme to avoid amplification of pseudogenes. A serious problem in the detection of tissue-specific transcripts in PBMNC is the detection of illegitimate transcription levels. In conclusion, although CK-19 may be a useful marker for the detection of lung cancer cells, its application for the detection of circulating tumor cells is not recommended.lld:pubmed
pubmed-article:9314945pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9314945pubmed:languageenglld:pubmed
pubmed-article:9314945pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9314945pubmed:citationSubsetIMlld:pubmed
pubmed-article:9314945pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9314945pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9314945pubmed:statusMEDLINElld:pubmed
pubmed-article:9314945pubmed:monthSeplld:pubmed
pubmed-article:9314945pubmed:issn0023-6837lld:pubmed
pubmed-article:9314945pubmed:authorpubmed-author:GiacconeGGlld:pubmed
pubmed-article:9314945pubmed:authorpubmed-author:PostmusP EPElld:pubmed
pubmed-article:9314945pubmed:authorpubmed-author:BrakenhoffR...lld:pubmed
pubmed-article:9314945pubmed:authorpubmed-author:DingemansA...lld:pubmed
pubmed-article:9314945pubmed:issnTypePrintlld:pubmed
pubmed-article:9314945pubmed:volume77lld:pubmed
pubmed-article:9314945pubmed:ownerNLMlld:pubmed
pubmed-article:9314945pubmed:authorsCompleteYlld:pubmed
pubmed-article:9314945pubmed:pagination213-20lld:pubmed
pubmed-article:9314945pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9314945pubmed:meshHeadingpubmed-meshheading:9314945-...lld:pubmed
pubmed-article:9314945pubmed:meshHeadingpubmed-meshheading:9314945-...lld:pubmed
pubmed-article:9314945pubmed:meshHeadingpubmed-meshheading:9314945-...lld:pubmed
pubmed-article:9314945pubmed:meshHeadingpubmed-meshheading:9314945-...lld:pubmed
pubmed-article:9314945pubmed:meshHeadingpubmed-meshheading:9314945-...lld:pubmed
pubmed-article:9314945pubmed:meshHeadingpubmed-meshheading:9314945-...lld:pubmed
pubmed-article:9314945pubmed:meshHeadingpubmed-meshheading:9314945-...lld:pubmed
pubmed-article:9314945pubmed:meshHeadingpubmed-meshheading:9314945-...lld:pubmed
pubmed-article:9314945pubmed:meshHeadingpubmed-meshheading:9314945-...lld:pubmed
pubmed-article:9314945pubmed:meshHeadingpubmed-meshheading:9314945-...lld:pubmed
pubmed-article:9314945pubmed:meshHeadingpubmed-meshheading:9314945-...lld:pubmed
pubmed-article:9314945pubmed:meshHeadingpubmed-meshheading:9314945-...lld:pubmed
pubmed-article:9314945pubmed:year1997lld:pubmed
pubmed-article:9314945pubmed:articleTitleDetection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients.lld:pubmed
pubmed-article:9314945pubmed:affiliationDepartment of Medical Oncology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands.lld:pubmed
pubmed-article:9314945pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9314945pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9314945lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9314945lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9314945lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9314945lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9314945lld:pubmed